7 NUTS Study. Diet Modification and Male Fertility.
Study Details
Study Description
Brief Summary
Setting. Outpatient fertility clinic.
Aim. Investigate if a modification in nutritional habits may improve in the short term the qualities of human sperm, testing two hypothesis:
- that adding to the diet a natural whole food rich in polyunsaturated fatty acids (PUFA)
OR
- that reducing the intake of saturated fatty acids and increasing the consumption of PUFA may affect beneficially sperm parameters.
Population. N. 100 hypofertile male subjects attending a fertility clinic.
Type of study. Interventional study. No drugs or pharmacologic supplementation will be required nor allowed.
Two different type of intervention are scheduled:
-
Supplementation to western style diet with nuts, naturally rich in PUFA
-
Diet modification increasing intake of PUFA-rich foods and cutting the consumption of food rich in saturated fats.
Protocol
-
Baseline visit and recruiting.
-
Informed consent
-
Randomized allocation to treatment group in a 1: 1 manner
Blinding. Investigators deputed to sperm analysis and statistician are blinded as to type of intervention.
Phases:
-
- basal
-
- after 15 weeks That interval is chosen because encompasses an entire spermatogenesis cycle.
Outcomes. Primary
- sperm count, concentration,morphology and mobility.
Secondary:
-
serum folate assay,
-
plasma PUFA (ALA, EPA, DHA) assay,
-
body weight and BMI variation
Statistics. A comparison for all sperm parameters (count,concentration,morphologic abnormalities, mobility) will be carried out by an analysis within groups and within patient.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Phase 2/Phase 3 |
Detailed Description
The planned trial is nutritional based only, with a modification of diet in order to obtain an increase of PUFA intake with/without a reduction of saturated fatty acid intake.
Two different types of intervention are scheduled:
-
Supplementation to western style diet with food naturally rich in PUFA
-
Diet modification, increasing intake of PUFA naturally rich foods and cutting the consumption of saturated fats.
The supplementation is obtained adding 7 nuts a day to regular diet. The diet modification is obtained by increasing intake of nuts and seeds (walnuts, hazelnuts, almonds, peanuts, sesame, sunflower, flaxseed) and derived oils, fish and vegetables; cutting the consumption of processed meat and dairy products is required as well.
The type of diet or supplementation is supported by oral and written information. The compliance to diet will be followed by administration of validated questionnaires.
The effect of the diet modifications will be followed by a number of plasma biomarkers we plan to compare at baseline and post intervention. The body weight and BMI will be checked, as both types of intervention are intended to not affect significantly mean body weight.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Active Comparator: 7 NUTS a day the patients allocated to this arm will be instructed to supplement their diet with 7 nuts a day (whole shelled weight around 75 grams) |
Dietary Supplement: 7 nuts a day
add 7 nuts a day (whole shelled weight 75 grams) to standard diet
|
| Experimental: Diet modification the patients allocated to this arm will be instructed to modify their diet allowing more intake of PUFA rich food avoiding saturated fat rich food |
Other: Diet modification
modify the diet allowing more intake of PUFA rich food and cutting the consumption of saturated fatty acids
|
Outcome Measures
Primary Outcome Measures
- sperm count [15 weeks]
Change in sperm count from baseline to 15 weeks
- sperm concentration [15 weeks]
change in sperm concentration from baseline to 15 weeks
- sperm motility [15 weeks]
change in sperm motility (% of progressive forms) from baseline to 15 weeks
- sperm morphology [15 weeks]
change in sperm morphology ( % normal forms ) from baseline to 15 weeks
Secondary Outcome Measures
- change in weight (BMI) [15 weeks]
change in body weight (BMI) from baseline to 15 weeks
- Change in serum cholesterol [15 weeks]
change in serum cholesterol levels from baseline to 15 weeks
- change in serum folate [15 weeks]
change in serum folate from baseline to 15 weeks
- change in plasma alpha linolenic acid (ALA) levels [15 weeks]
change in ALA levels from baseline to 15 weeks
- change in plasma eicosapentaenoic acid (EPA) [15 weeks]
change in plasma EPA levels from baseline to 15 weeks
- change in plasma docosahexaenoic acid (DHA) [15 weeks]
change in plasma DHA levels from baseline to 15 weeks
Eligibility Criteria
Criteria
Inclusion Criteria:
-
sperm concentration > 5.000.000 ml
-
progressive motile forms < 35%
-
BMI < 30
-
normal FSH (Follicle Stimulating Hormone reference values 1-10 IU)
Exclusion Criteria:
-
allergy to nuts or seeds
-
clinical varicocele
-
recent surgery for varicocele
-
vasectomy
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Ospedale Sant'Anna. Dipartimento di Ostetricia e Neonatologia. S.C. Biochimica Clinica "Baldi e Riberi" Settore Malattie Metaboliche - Dipartimento di Medicina di Laboratorio A.O.U. Citta' della Salute e della Scienza Presidio San Giovanni Battista - Moli | Torino | Italy | 10126 |
Sponsors and Collaborators
- Azienda Ospedaliera Città della Salute e della Scienza di Torino
Investigators
- Principal Investigator: Aldo Maina, MD, Ospedale Sant'Anna Medicina Interna. Azienda Ospedaliera Universitaria Città della Salute e della Scienza Torino Italy
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- CS93-2013